We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Myriad Genetics Inc | NASDAQ:MYGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.09 | -0.39% | 23.20 | 20.84 | 24.24 | 23.43 | 22.35 | 23.01 | 927,641 | 22:39:55 |
From Jun 2019 to Jun 2024
Myriad Genetic (MYGN) shares jumped 8% to $87.91 on Wednesday, following news that the American College of Obstetricians and Gynecologists is recommending doctors routinely evaluate whether a patient is at risk of carrying a genetic mutation of the BRCA1 or BRCA2 gene.
As carriers of the mutation generally have a markedly higher risk of developing breast or ovarian cancer, doctors may choose to take preventative measures, such as removal of the ovaries and fallopian tubes.
Myriad markets a genetic screening test for the BRCA1 and BRCA2 mutations called BRACAnalysis.
1 Year Myriad Genetics Chart |
1 Month Myriad Genetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
